Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I
- PMID: 2205849
- DOI: 10.1016/1043-6618(90)90756-4
Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I
Abstract
Human mononuclear cells derived from peripheral blood of adult donors (PBMC) or from neonatal cord blood (CBMC) were found to be equally sensitive to the protective effect of alpha- and beta-interferons (IFNs) against the infection with HTLV-I during long-term culture. The effect of IFNs was evidenced by a remarkable reduction of the number of virus-positive cells during culture as evaluated by indirect immunofluorescence for the p19 virus core protein. Moreover, the appearance of p19-positive immortalized clones was inhibited by IFNs in PBMC co-cultures, whereas it was delayed in CBMC cultures. These kinetics are in relation with the higher permissivity of CBMC to the virus in comparison with PBMC, since in CBMC cultures infected cells can be clearly detected starting already 1 week post-infection (p.i.), whereas in PBMC cultures their appearance time is approximately at the 6th week p.i. IFNs acted by 'priming' PBMC and CBMC to an active antiviral competence, since one single treatment with 1000 IU/ml of alpha- or beta-IFN at the onset of the co-culture of mononuclear cells with irradiated virus-donor cells was able to maintain very low levels of infection for approximately 6 weeks in CBMC cultures and at least for 18 weeks in PBMC cultures. As a consequence, it seems likely that IFN action is mediated by the expression of a defined, although not completely identified, set of genes in the host cells.
Similar articles
-
Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.Cancer Immunol Immunother. 1993 Jul;37(2):97-104. doi: 10.1007/BF01517041. Cancer Immunol Immunother. 1993. PMID: 8100486 Free PMC article.
-
Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.Cancer Immunol Immunother. 1990;31(4):213-20. doi: 10.1007/BF01789171. Cancer Immunol Immunother. 1990. PMID: 2116232 Free PMC article.
-
Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cells.Int J Immunopharmacol. 1993 Feb;15(2):125-36. doi: 10.1016/0192-0561(93)90088-g. Int J Immunopharmacol. 1993. PMID: 8468116
-
Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro.Int J Immunopharmacol. 1992 Aug;14(6):1069-79. doi: 10.1016/0192-0561(92)90152-b. Int J Immunopharmacol. 1992. PMID: 1428362
-
Modulation of B-cell immunoglobulin synthesis by retinoic acid.Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 2):S73-81. doi: 10.1006/clin.1996.0144. Clin Immunol Immunopathol. 1996. PMID: 8811066 Review.
Cited by
-
Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.Viruses. 2018 Dec 5;10(12):691. doi: 10.3390/v10120691. Viruses. 2018. PMID: 30563084 Free PMC article. Review.
-
Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.Cancer Immunol Immunother. 1993 Jul;37(2):97-104. doi: 10.1007/BF01517041. Cancer Immunol Immunother. 1993. PMID: 8100486 Free PMC article.
-
Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.Cancer Immunol Immunother. 1990;31(4):213-20. doi: 10.1007/BF01789171. Cancer Immunol Immunother. 1990. PMID: 2116232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials